AI Science Tracker

A protein-language-model workflow discovers high-activity kynureninase enzymes for tumor models

Seoul National University; and Galux Inc. · 7 Jan 2025 · medicine

Discovery

A protein-language-model workflow discovers high-activity kynureninase enzymes for tumor models

A workflow combining homology search, protein-language-model embeddings and regression prioritized kynureninases by predicted catalytic activity. Researchers experimentally tested four top-ranked candidates; the most active had nearly twice the turnover number of the prior best, and enzyme treatment was associated with a 3.4-fold reduction in tumor weight in a mouse comparison.

Technology: Protein language model embeddings coupled with regression in the SeekRank enzyme-prioritization workflow

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Researchers experimentally tested four top-ranked candidates; the most active had nearly twice the turnover number of the prior best, and enzyme treatment was associated with a 3.4-fold reduction in tumor weight in a mouse comparison.
  • Still unknown: The evidence is a published paper abstract; it describes an enzyme/treatment experiment in a mouse tumor model, not clinical efficacy. The reported tumor-weight reduction is model-specific; no claim of human therapeutic benefit is made.
  • AI role: The model represented homologous kynureninase sequences with protein-language-model embeddings and regressed kinetic activity to rank enzyme candidates. Four high-ranked candidates were tested in vitro and in vivo; the abstract reports one with nearly two-fold improved turnover number and reduced tumor weight in a mouse model.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/39777462/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 82 of works of the same type, year and subfield (OpenAlex work metrics, 14 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.